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ABSTRACT 
Antioxidants are widely used as reactive oxygen species (ROS) scavenging 
agents in experimental research and in conditions where oxidative stress 
plays a primary role. However, the effect of antioxidant supplementation on 
white and brown adipose tissue functionality is understudied, and the role of 
ROS and/or antioxidant treatment during adipose tissue browning, a process 
in which the adipocytes’ mitochondrial density and activity increase, is 
largely unknown. In paper I, by using antioxidants and ROS-sensitive 
fluorescent probes in cultured β3-AR-stimulated adipocytes, we observed 
that 24-48-hour antioxidant treatment increases the mitochondrial ROS 
production associated with reduced respiration and increased glycolysis. 
Moreover, treatment of mice with the antioxidant N-acetylcysteine (NAC) 
blunted the β3-AR agonist-induced browning response of white adipose 
tissue and reduced the mitochondrial activity in brown adipose tissue even in 
the absence of β3-AR stimulation. Previous studies have shown positive 
effects of prolonged NAC treatment on whole-body metabolism in mice. In 
light of these seemingly contradictory results, we hypothesize that chronic 
antioxidant exposure, in a dose-dependent manner, can lead to so-called 
mitohormesis. Indeed, in paper II, by treating mice with a set of different 
NAC doses across a defined time course, we found that prolonged 
supplementation with a high dose of NAC leads to increased mitochondrial 
function of white adipose tissue, reduced fat mass and improved insulin 
sensitivity. In summary, this thesis demonstrates that the adipose tissue 
response to antioxidant treatment in mice is biphasic and tightly connected to 
the adipose tissue type, the dosage and the treatment duration. This thesis 
also provides an alternative explanation for previously reported controversial 
findings where antioxidants (such as NAC) have exerted deleterious effects 
on health. Finally, the results of this thesis provide new insights into the 
appropriate design of antioxidant treatment studies: optimizing treatment 
dosage and duration may be the key to achieve success with antioxidant 
therapy. 
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 SAMMANFATTNING PÅ SVENSKA 
I denna studie har vi undersökt effekten av antioxidantbehandling på 
fettvävens mitokondriefunktion. Våra huvudsakliga fynd är att antioxidanter 
kan, beroende på dosering och behandlingslängd, öka den mitokondriella 
produktionen av fria syreradikaler. Detta är dock inte nödvändigtvis av ondo 
utan kan över tid leda till förbättrad mitokondriefunktion, åtminstone i 
fettväven. 
Fettväv som ökar sin mängd aktiva mitokondrier blir bättre på att ta upp fett 
och socker från blodbanan, vilket minskar risken för att kärl och andra organ 
förfettas. I mitokondrierna omvandlas näringsämnen till kemisk energi i en 
syrekrävande process som kallas cellandning. I denna process bildas även fria 
syreradikaler som kan orsaka skadlig oxidativ stress. Det är därför vanligt att 
kosttillskott innehåller antioxidanter som kan neutralisera dessa syreradikaler. 
Antioxidanter används även i forskningssammanhang för att försöka förbättra 
sjukdomstillstånd i vilka man tror att oxidativ stress är en bidragande orsak, 
som till exempel diabetes och neurodegenerativa sjukdomar. I flera 
vetenskapliga studier har det dock visat sig att antioxidantbehandling inte har 
några positiva effekter och i vissa fall har till och med negativa utfall 
rapporterats. 
I delarbete I fann vi att antioxidantbehandling paradoxalt nog kan öka den 
mitokondriella produktionen av fria syreradikaler i odlade fettceller. Denna 
effekt är kopplad till en sänkt cellandning. Vi fick liknande resultat i möss; 
möss behandlade med antioxidanten N-acetylcystein under två veckor fick 
försämrad mitokondriefunktion i fettväven än kontrollmössen. I andra 
musstudier har det dock rapporterats att långtidsbehandling med N-
acetylcystein ökar fettvävens mitokondriemängd samt förbättrar kroppens 
ämnesomsättning. I delarbete II förklarar vi dessa motsatta resultat genom att 
påvisa en så kallad hormetisk effekt av N-acetylcystein i musfettväv. 
Hormesis innebär att en giftig substans eller en stressor, i ett visst 
dosintervall, kan ge fördelaktiga effekter till följd av att cellen anpassar sig. 
Våra data tyder på att den paradoxala ökningen av fria syreradikaler till följd 
av N-acetylcysteinbehandling kan uppreglera fettvävsmitokondriernas egna 
antioxidantsystem samt produktion av fler och/eller effektivare mitokondrier, 
vilket resulterar i sänkt fettmassa och förbättrad ämnesomsättning. 
Resultaten från denna studie ger oss således fördjupad kunskap om möjliga 
utfall av antioxidantbehandling samt en ny förklaringsmodell för tidigare, 
tillsynes motsägelsefulla fynd. 
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1 INTRODUCTION 
Obesity is defined by the World Health Organization as an excessive fat 
accumulation in the body and is considered a major risk for diseases such as 
diabetes, cardiovascular diseases (mainly heart diseases and stroke) (Lavie, 
Milani et al. 2009), musculoskeletal disorders (especially osteoarthritis) 
(Wearing, Hennig et al. 2006) and several cancers (including endometrial, 
breast, ovarian, prostate, liver, gallbladder, kidney, and colon) (Stone, 
McPherson et al. 2018). However, it is not increased adiposity per se, but 
rather the obesity-associated adipose tissue dysfunction that increases the risk 
of developing co-morbidities. Dysfunctional adipose tissue contributes to the 
metabolic syndrome, whereas healthy adipose tissue, regardless of its size, is 
protective through its ability to remove excess nutrients from the blood 
stream. To increase our knowledge about the pathogenesis of obesity-related 
diseases and to identify new therapeutic targets it is, therefore, important to 
delineate mechanisms that regulate adipose tissue functionality. 
1.1 ADIPOSE TISSUE AND ADIPOCYTES 
The adipose tissue is distributed throughout the body and plays a central role 
in the regulation of whole-body energy homeostasis. It can expand and shrink 
dramatically to store and release energy to accommodate the body’s need. 
Adipose tissue displays thus an extreme flexibility compared to other tissues 
and organs. In mammals, the adipose tissue is classified as either white or 
brown containing respectively, white adipocytes, which are the primary site 
of triglyceride/energy storage, and brown adipocytes, which are mainly 
responsible of thermogenesis i.e. dissipating energy as heat (Gesta, Tseng et 
al. 2007). In humans, adipose tissue accounts for around 20 % of the total 
body weight and the amount increases to more than 40 % in obesity (Sepa-
Kishi and Ceddia 2018). 
1.1.1 WHITE ADIPOSE TISSUE 
The classical fat cell, the white adipocyte, is a spherical, large and 
expandable cell that usually contains one large lipid droplet accounting for 95 
% of the cell volume. Its mitochondrial content is relatively low and its main 
role is to store excess energy in the form of triglycerides and, when required, 
deliver energy back to the body through lipolysis leading to the release of 
glycerol and fatty acids. The adipocytes also have a very important role as 
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hormone/adipokine producers. For instance, the adipokines leptin and 
adiponectin contribute to the regulation of whole-body energy balance and 
metabolism (Balistreri, Caruso et al. 2010). Other cell types but adipocytes 
account for around 50 % of the total cell population in adipose tissue. They 
are collectively termed the stromal vascular fraction (SVF). The SVF 
includes preadipocytes, various immune cells such as macrophages and 
lymphocytes, endothelial cells and pericytes (Bourin, Bunnell et al. 2013) 
and these SVF cells provide the necessary means for normal adipose tissue 
growth and homeostasis. 
Anatomically, white adipose tissue (WAT) comprises two major depots: the 
subcutaneous and the visceral WAT. In humans, the subcutaneous WAT is 
mainly found in the abdominal, gluteal and femoral regions, while the 
visceral WAT is found around internal organs in the mesentery and the 
omentum. The same anatomical division holds true for mice. However, mice 
have a rather large fat depot surrounding their gonads, the gonadal WAT 
(GWAT), which is a visceral depot not found in humans (Chusyd, Wang et 
al. 2016). Although having the same lineage of origin, different anatomical 
location of adipose tissue is associated with different functionality, connected 
to the protein expression signature in both humans (Vidal 2001) and mice 
(Gesta, Blüher et al. 2006). Importantly, excess visceral WAT is highly 
correlated with increased risk of metabolic disorders such as insulin 
resistance and type 2 diabetes (Item and Konrad 2012), whereas increased 
subcutaneous WAT has been connected to low risk of the metabolic 
syndrome (Kissebah and Krakower 1994) (Figure 1). 
Figure 1. Fat distribution influences risks associated with obesity in humans. Gesta 
et al., published in Cell (2007).  
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1.1.2 BROWN ADIPOSE TISSUE 
In contrast to white adipocytes, brown adipocytes are ellipsoid-shaped small 
cells with multilocular lipid droplets. The brown color of brown adipose 
tissue (BAT) is primarily due to a high mitochondrial content of the resident 
adipocytes, which specifically express uncoupling protein 1 (UCP1) also 
known as thermogenin. Indeed, BAT is a specialized organ that is critically 
important for heat generation and lipid oxidation (Richard and Picard 2011). 
In humans, it is present in newborns (Cannon and Nedergaard 2004) but 
decreases quickly and has been considered insignificant in adults. However, 
more recent studies indicate that human BAT is not as insignificant as once 
believed (Nedergaard, Bengtsson et al. 2007), but may regulate whole-body 
metabolism even in adulthood (Cypess, Lehman et al. 2009). In rodents, BAT 
is mainly located in the interscapular region and plays an important role in 
temperature regulation and metabolism across their whole life. 
Interestingly, fate-mapping studies combined with cell sorting analysis have 
shown that distinct mesenchymal progenitors give rise to white and brown 
adipocytes. Skeletal muscle cells and preformed brown adipocytes share a 
common ancestry and originate from myogenic factor 5 (MYF5)-expressing 
precursor cells, while white adipocytes originate from precursor cells that are 
MYF5 negative (Timmons, Wennmalm et al. 2007). Brown and white 
adipocytes display in many ways opposite functions although both contain 
lipids and play a crucial role in whole-body metabolism. 
1.2 BROWNING 
Browning of WAT can be defined as a process where there is a significant 
increase in adipocyte UCP1 levels. The resultant adipocytes are referred to as 
beige, brite (brown-to-white), convertible, ectopic, inducible or recruitable 
adipocytes (Nedergaard and Cannon 2014). Simply speaking, adipose tissue 
browning is thus the process of turning white adipocytes into brown-like 
adipocytes that display increased mitochondrial content, increased UCP1 
levels and elevated metabolic rate. 
Adipose tissue browning can be triggered by cold temperature, food 
components, gene modifications or drugs. The list of browning agents is 
growing rapidly, and more than 50 agents have been identified (Wu, Cohen et 
al. 2013). The first report of a browning process shows increased UCP1 
expression in clusters of GWAT adipocytes in BALB/c mice exposed to cold 
temperature (Young, Arch et al. 1984). The browning process has thus been 
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studied during many years, but it was not until the last decade that the term 
“browning” became broadly used. The current paradigm is that browning can 
be triggered by two different pathways (Nedergaard and Cannon 2014): 
- Through pharmacological or sympathetic nerve 
system-mediated activation of β-adrenergic receptors 
(β3-AR) in white adipocytes. 
- Through pharmacological induction of the peroxisome 
proliferator-activated receptor γ (PPARγ) pathways. 
Both these pathways involve three master regulators of the browning process: 
PPARγ, PR domain containing 16 (PRDM16) and peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC1α). 
In 2014, a new mechanism driving cold-induced browning process in vivo is 
suggested (Qiu, Nguyen et al. 2014). In brief, Qiu and colleagues propose 
that cold temperature is associated with an increased local production of 
catecholamines by WAT-resident M2-polarized macrophages. These 
catecholamines stimulate β3-ARs leading to increased expression of 
thermogenic genes in adipocytes. However, this suggested mechanism 
remains controversial (Fischer, Ruiz et al. 2017). Moreover, it is not clear 
whether cold temperature exposure and pharmacological activation of the β3-
AR stimulate the same cell populations that finally results in browning 
(Jiang, Berry et al. 2017). Thus, different browning agents are likely 
triggering distinct pathways in different adipocytes and/or precursor cells 
leading to slightly different browning processes although the final result may 
appear similar. One of the most used methods to study the browning process 
and its consequences is however pharmacological stimulation of the β3-AR. 
Amongst several options, a compound named CL316,243 is widely used 
because of its high specificity and potency (Peng, Gennemark et al. 2015). 
1.2.1 BEIGE ADIPOCYTES 
The beige adipocyte is considered to be a distinct cell type that has mixed 
characteristics from both white and brown adipocytes. They are spherical 
cells, smaller than white adipocytes with increased mitochondrial content and 
multilocular lipid content. Upon stimulation they can activate their 
thermogenic capacity through increased UCP1 expression. In mice, beige 
adipocytes are dispersed mainly across subcutaneous white adipose tissue 
while fewer are to be found in visceral depots (Wu, Boström et al. 2012). 
Furthermore, beige adipocytes have been suggested to possess a distinct gene 
expression signature as compared to white and brown adipocytes (Wu, 
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Boström et al. 2012, Harms and Seale 2013), although the full validity of this 
signature has been questioned and more flexible borders between adipocyte 
cell types have been described (de Jong, Larsson et al. 2015). 
There are studies showing that beige adipocytes share lineage of origin with 
white adipocytes (they are both MYF5
-
) (Seale, Bjork et al. 2008), but upon 
stimulation they can transform their morphology to acquire the appearance 
and protein expression profile of brown adipocytes (Seale, Conroe et al. 
2011). However, some beige cells have been shown to originate from the 
MYF5
+
 lineage, suggesting heterogeneity within beige adipocytes (Sanchez-
Gurmaches, Hung et al. 2012) (Figure 2). 
Figure 2. Model of adipose tissue (BAT, interscapular WAT (iWAT), retroperitoneal 
WAT (rWAT), inguinal (ingWAT) , perigonadal (pgWAT ) adipocyte development 
based on lineage analysis, image based on Sánchez-Gurmaches et al., in Cell 
Metabolism (2012) *Different acronyms are used on this figure compared to this 
thesis. 
Besides the origin of beige adipocytes, their formation is also debated. There 
are studies supporting the notion that beige adipocytes are recruited via de 
novo adipogenesis (Wu, Boström et al. 2012), but there are also several 
studies supporting the so-called transdifferentiation theory where beige 
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adipocytes originate from white adipocytes that are reprogrammed into 
brown-like adipocytes (Barbatelli, Murano et al. 2010). 
Regardless of their lineage of origin and their formation process, beige 
adipocytes have become of great interest as a potential therapeutic target to 
reduce obesity-related co-morbidities. Beige adipocytes may reduce body 
weight via increased non-shivering thermogenesis (Kopecky, Rossmeisl et al. 
2001, Kazak, Chouchani et al. 2015, Ikeda, Maretich et al. 2018) and/or 
increased oxidative capacity associated with improved whole-body 
metabolism (Granneman, Li et al. 2005, Duteil, Metzger et al. 2014). 
1.3 MITOCHONDRIA 
Mitochondria are cytoplasmic organelles found in most eukaryotic 
organisms. Their main role is energy biogenesis, typically providing 90 % of 
the cellular energy via the electron transport chain/ATP production. 
Therefore, they are usually termed the powerhouse of the cell. However, they 
are also involved in other cellular processes such as apoptosis, Ca
2+
-signaling 
and redox homeostasis (Duchen and Szabadkai 2010, Spinelli and Haigis 
2018). 
Mitochondria have a double membrane arrangement which separates the 
organelle into four distinct compartments: the outer membrane, the 
intermembrane space, the inner membrane, and the matrix. The outer 
membrane is quite permeable and controls diffusion of molecules into the 
space between the outer and inner membranes. The intermembrane space 
contains proteins that play major roles in mitochondrial energetics and 
apoptosis. In contrast to the outer membrane, the inner membrane is highly 
impermeable and most ions and molecules require transporters to cross. It 
contains around 20 % of the total mitochondrial protein composition, 
amongst which are protein transporters into the matrix (e.g. translocase of the 
inner membrane) and the enzymes of the electron transport chain. In order to 
expand the capacity for chemical reactions, the area of this membrane is 
increased by several cristae, i.e. folds in the inner membrane. The matrix 
contains most of the enzymes that are responsible for the reactions of the 
citric acid cycle (McCarron, Wilson et al. 2013). 
Mitochondria cannot be generated de novo, thus new organelles arise from 
pre-existing ones, through a multi-step process which involves both fusion 
and fission events. This is a tightly regulated process, dependent on the 
activity of both mitochondrial and nuclear factors. PGC1α is a major 
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regulator of mitochondrial biogenesis, activating different transcription 
factors such as nuclear respiratory factor 1 and 2, that further promote 
transcription of key mitochondrial enzymes (Jornayvaz and Shulman 2010). 
The cyclic adenosine monophosphate (cAMP) level is one of the upstream 
signals that regulate the expression of PGC1α. Interestingly, β3-AR 
activation results in increased cAMP levels, leading to the protein kinase A 
(PKA)-dependent activation of the cAMP response element-binding protein 
(CREB), which in turn upregulates PGC1α expression, resulting in new 
mitochondria. 
The mitochondrial content and function in adipocytes are tightly linked to the 
cell type. White adipocytes contain few mitochondria that primarily functions 
as ATP-producers, but they also provide key intermediates needed for de 
novo lipogenesis such as glycerol 3-phosphate and acetyl-CoA (Cedikova, 
Kripnerov et al. 2016). Beige adipocytes, prior activation, have a slightly 
higher mitochondrial content with similar basal UCP1 levels as white 
adipocytes (Wu, Boström et al. 2012). Upon stimulation, their UCP1 level 
increases together with an increment in mitochondrial content (Velazquez-
Villegas, Perino et al. 2018). Brown adipocytes contain many mitochondria, 
whose activity is dedicated mostly to non-shivering thermogenesis 
(Cedikova, Kripnerová et al. 2016). 
1.3.1 UCP1 
Non-shivering thermogenesis in brown (and beige) adipocytes’ mitochondria 
is essentially dependent on UCP1. This protein is a 33kDa monomer, 
composed by 306 amino acids, that is encoded by nuclear DNA. The 
structure of the UCP1 gene is highly conserved in mouse, rat and human: six 
exons encompass the coding sequence and each exon encodes a 
transmembrane domain (Ledesma, de Lacoba et al. 2002). Its sequence is 
also highly homologous among species, suggesting an important role in 
metabolism. It is mainly expressed in brown adipocytes but also in activated 
beige adipocytes (Nedergaard, Golozoubova et al. 2001, Wu, Boström et al. 
2012) and in other cell types such as thymocytes (Adams, Carroll et al. 
2008). 
UCP1 acts as a proton transporter over the mitochondrial inner membrane. It 
mediates the passive re-entry of protons into the mitochondrial matrix, 
producing heat and concomitantly decreasing the yield of ATP .Thus, UCP1-
mediated uncoupling of the electron transport chain enables the oxidative 
metabolism to run at maximal rate leading to increased heat production 
Adipose tissue mitochondrial function is modulated by antioxidants 
8 
(Labbe, Caron et al. 2015). Moreover, UCP1 is activated by fatty acids and 
inhibited by ATP (Jastroch, Divakaruni et al. 2010) and the Ucp1 gene is 
under extensive transcriptional control: in response to cold temperature or 
overfeeding, activation of β-ARs initiates a cAMP signal transduction 
pathway that activates Ucp1 transcription mediated by three nuclear 
receptors: PPARγ, thyroid hormone receptor (TR) and retinoic acid receptor 
(RXR) (Divakaruni and Brand 2011) and the essential coactivator PGC1α 
(Puigserver, Wu et al. 1998) as shown in Figure 3. 
Figure 3. Ucp1 transcription regulation through β-AR activation. Lowell et al., 
published in Nature (2000). 
1.3.2 REACTIVE OXYGEN SPECIES 
Reactive oxygen species (ROS) are chemically reactive species containing 
oxygen, generated by cells. There are radical molecules such as superoxide 
(O2
-•
), peroxyl (RO
•
) and hydroperoxyl (HO2
•
) and non-radical ones e.g. 
hydrogen peroxide (H2O2), but the degree of reactivity is independent of 
having unpaired electrons (Stowe and Camara 2009). In adipocytes, there are 
many ROS sources: 
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- Mitochondria, which harbor the bulk of oxidative 
pathways, contain many enzymatic complexes that 
potentially can transfer single electrons to oxygen and 
convert it into superoxide anion in a process referred to 
as electron leak (Jastroch, Divakaruni et al. 2010). 
- Nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase is described as a major contributor 
of ROS in adipocytes (Han, Umemoto et al. 2012). 
- Nitric oxide synthase can, under certain pathological 
conditions, be uncoupled to produce superoxide (Le 
Lay, Simard et al. 2014). 
The basic initiating step in ROS production is the single reduction 
(transferring of one electron) of molecular oxygen into superoxide 
(Andreyev, Kushnareva et al. 2015). This reaction is the rate-limiting step in 
the whole cascade. Once formed, it is involved in several reactions that, in 
turn, generate other ROS such as hydrogen peroxide, hydroxyl radical (OH
•
), 
peroxynitrite (ONOO
-
) and hypochlorous acid (HOCl) (Pizzino, Irrera et al. 
2017). 
ROS have long been considered inevitable by-products of cellular processes. 
0.15 to 2 % of the consumed O2 during respiration is reduced by single 
electrons, generating superoxide (Brand 2010). ROS can react with DNA, 
proteins and phospholipids leading to an irreversible damage to the cell. 
However, in recent years, accumulating evidence indicates that ROS also 
serve as critically important signaling molecules in cell proliferation and 
survival (Ray, Huang et al. 2012). Therefore, a tight control of ROS 
production and elimination is required for cell homeostasis. 
1.3.3 REDOX REGULATION 
Systems to control ROS and the redox state under physiological conditions 
are spread throughout the cell. Indeed, it is equipped with enzymatic and 
nonenzymatic antioxidants that eliminate ROS and maintain redox 
homeostasis. 
Superoxide dismutases (SOD) are a major class of enzymatic antioxidants, 
which catalyze the dismutation of O2
-•
 to H2O2 without any support of 
reducing equivalents for their ROS decomposition activity. There are 
multiple isoforms that can be found in different cellular compartments 
(Trachootham, Lu et al. 2008). SOD1, which contains Cu and Zn and is 
found in the cytoplasm, mitochondrial intermembrane space, nucleus, and 
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lysosomes, accounts for 70-80 % of the total cellular SOD activity (Halliwell 
1989). SOD2, a key mitochondrial antioxidant enzyme which contains Mn, is 
mainly found in the mitochondrial matrix (Fukui and Zhu 2010). SOD3 is an 
extracellular Cu/Zn dismutase that is expressed in a limited number of tissues 
(Ookawara, Imazeki et al. 1998). 
Hydrogen peroxide, the resulting product of SOD activity, can be neutralized 
by three different defense systems: catalases, thioredoxins (TRX) / 
peroxiredoxins (PRDX) and/or glutathione-based. 
Catalase is an enzyme that catalyzes dismutation of hydrogen peroxide to 
oxygen and water, and is present in all aerobic cells. It is located in 
peroxisomes and is one of the most efficient enzymes known, resulting in 
reaction rates approaching the diffusion-controlled limit (Vainshtein, Melik-
Adamyan et al. 1981). 
The second system for hydrogen peroxide clearance includes the tandem 
TRX / PRDX that, as a whole system, scavenge hydrogen peroxide and use 
NADPH as a reducing agent. Similarly to SODs, there are multiple isoforms 
of PRDX that can be found in different subcellular locations (Wood, 
Schroder et al. 2003). Briefly, hydrogen peroxide is reduced to water by 
PRDX, in a two-step reaction. The resulting oxidized form of PRDX is 
reduced back by TRX, which in the end will be reduced by NADPH 
(Hanschmann, Godoy et al. 2013). Interestingly, PRDX3, in the 
mitochondrial matrix, contributes to around 90 % of the total ROS removal 
(Andreyev, Kushnareva et al. 2015). 
The last system is based on glutathione. Glutathione (γ-glutamylcysteinyl-
glycine) is a thiol-containing tripeptide that is found at high concentrations 
(1–10 mM) in all eukaryotes and many prokaryotic species (Sikanyika, 
Aragao et al. 2019). Glutathione can exist in a reduced state (GSH) or an 
oxidized state (GSSG), which consists of two GSH molecules that are linked 
together by a disulfide bond. Different subcellular locations harbor different 
glutathione pools. For example, the cytosolic glutathione pool is highly 
reduced, with a GSH:GSSG ratio in the order of 100:1, whereas the ratio in 
the mitochondrial matrix is around 30:1 (Zhang, Limphong et al. 2012). GSH 
is exclusively produced in the cytosol and is further transported into the 
mitochondrial matrix (Calabrese, Morgan et al. 2017). Similar to 
peroxiredoxins, hydrogen peroxide in the mitochondria can be reduced by 
glutathione peroxidase, using GSH as substrate, producing GSSG. This 
oxidized molecule can be reduced back to GSH using NADPH as a reducing 
equivalent by glutathione reductase. 
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The hydrogen peroxide removal systems rely on the NADPH/NADP
+
 redox 
state to be efficient. Thus, optimal mitochondrial bioenergetics function is 
required for the proper antioxidant activity of these systems. Moreover, there 
is a complex interaction between PRDXs, TRXs and the glutathione systems 
in the mitochondrial matrix; a slight change in the balance of one of these 
systems may change the redox state of the whole cell and thereby affect many 
cellular functions including metabolic processes. 
1.4 MITOCHONDRIAL DYSFUNCTION 
Mitochondrial dysfunction is a term that has been used to define the 
incapacity of mitochondria to generate and sustain sufficient ATP levels, 
through oxidative phosphorylation (OXPHOS), in response to energy 
demands (Kusminski and Scherer 2012). However, it can also be applied to 
describe all maladaptive physiological responses of mitochondria involving 
processes such as substrate catabolism, calcium buffering, iron transport, 
intracellular mitochondrial shape and location, apoptosis, and ROS 
production. Specifically in white adipocytes, the alterations in mitochondrial 
function can e.g. involve impaired oxidative capacity, elevated ROS 
production and/or altered mitochondrial turnover (Boudina and Graham 
2014). 
Oxidative stress is the specific term to describe the mitochondrial dysfunction 
that includes an elevation in ROS production and/or incapacity of the cellular 
defense system to neutralize ROS (Schieber and Chandel 2014). Main 
consequences of oxidative stress in WAT are impairment in adipogenesis 
leading to adipocyte hypertrophy, tissue inflammation and insulin resistance 
(Castro, Grune et al. 2016). Etiology of obesity-associated type 2 diabetes has 
been connected to excessive nutritional overload, leading to increased lipid-
induced ROS formation (Kusminski and Scherer 2012) which, if sustained 
over time, can lead to chronic oxidative stress that results in e.g. insulin 
resistance (Houstis, Rosen et al. 2006) and reduced adiponectin secretion 
(Wang, Wang et al. 2013). 
On the other hand, reductive stress, a less appreciated concept than oxidative 
stress, is defined as an excess of reducing equivalents (NADPH and/or GSH) 
in the presence of intact oxido-reductive systems (Brewer, Mustafi et al. 
2013). However, similarly to oxidative stress, it has been connected to 
mitochondrial dysfunction (Zhang, Limphong et al. 2012), insulin resistance 
(Kobayashi, Matsuda et al. 2009) and etiology of many diseases (Pérez-
Torres, Guarner-Lans et al. 2017). 
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Overall, both alteration of the redox homeostasis, oxidative or reductive 
stress, have deleterious effects on mitochondrial function that if chronically 
sustained, have negative implications in metabolism. 
1.5 ANTIOXIDANTS 
Antioxidant supplementation has been suggested to assist the cellular 
defenses to overcome the excess of ROS in several pathologies. Vitamins and 
cofactors such as vitamin C, E or carnitine together with polyphenols and 
carotenoids, commonly used as supplements, have been tested due to their 
high availability in food sources (Abdali, Samson et al. 2015). These 
supplements have been studied in a broad range of diseases, such as 
diabetes/metabolic syndrome (Abdali, Samson et al. 2015), atherosclerosis 
(Packer, Weber et al. 2001), cancer (Sayin, Ibrahim et al. 2014) or processes 
where ROS are considered to play an important role e.g. physical exercise 
(Ristow, Zarse et al. 2009). 
More sophisticated compounds, that have a direct effect on mitochondria 
redox status, have also been studied. MitoQ, a derivative of ubiquinone 
conjugated to triphenylphosphonium (TPP
+
), is accumulated in the 
mitochondrial matrix and has been used in animal models and in patients 
(Oyewole and Birch-Machin 2015). 
N-acetylcysteine (NAC) has been suggested to possess antioxidant properties 
both by direct reaction of its sulfhydryl group with ROS or by increasing 
cellular GSH levels (Kelly 1998, Mokhtari, Afsharian et al. 2017). It has been 
broadly studied in animal models and patients in a wide range of conditions 
such as chronic obstructive pulmonary disease, HIV, cancer and insulin 
resistance (Kelly 1998, Fulghesu, Ciampelli et al. 2002, El Midaoui, Ismael 
et al. 2008). 
Antioxidant treatment studies in patients and mouse models have reported 
conflicting results i.e. positive effects where harmful oxidative stress is 
reduced (Udupa, Nahar et al. 2012), no impact on ROS levels (Choi and Ho 
2018) or deleterious outcomes such as increased levels of oxidative stress 
markers in blood, prevention of health-promoting effects of physical exercise, 
or increased melanoma progression (Kleinveld, Demacker et al. 1992, 
Ristow, Zarse et al. 2009, Le Gal, Ibrahim et al. 2015). 
For NAC specifically, there are experimental mouse studies where an 
improvement in mitochondrial function by reduction of oxidative stress is 
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reported (Wright, Renoir et al. 2015) whereas in in vitro, there are reports 
showing that NAC causes reductive stress, leading to mitochondrial 
dysfunction (Zhang, Limphong et al. 2012). 
Overall, the administration method, treatment length and dosage appear 
extremely important for the final outcome of antioxidant supplementation. 
1.6 HORMESIS 
Hormesis is defined as an adaptive response of cells and organisms to a 
moderate (usually intermittent) stress (Mattson 2008). It is a process that was 
first observed in the 19
th
 century in yeast exposed to small doses of toxins, 
which oppositely to what one expected, showed increased growth rate and 
metabolism. It was not until 1943 the term hormesis, using the Greek word 
for “excite”, was used to describe this U-shaped dose–response relationships 
(Southam 1943). The hormesis concept has thereafter been applied to 
different aspects of cellular behavior, but mitochondrial hormesis 
(mitohormesis) was not mentioned until 2006 (Tapia 2006). Analyzing 
previously published data, Tapia suggests that intermittent induction of ROS 
in mitochondria (mild oxidative stress), by different interventions such as: 
dietary restriction, exercise, consumption of pro-oxidant or mitochondrially 
injurious biochemical compounds might exert protective effects through 
beneficial cellular adaptations to these ROS increases. Since then, 
mitohormesis has been shown in C. Elegans using DNA mutagens (Yang and 
Hekimi 2010), using antioxidants (Oh, Park et al. 2015) and glucose 
restriction (Schulz, Zarse et al. 2007), in cardiac and skeletal muscles using 
statins (Bouitbir, Charles et al. 2012), myoblasts using antioxidants (Singh, 
Charles et al. 2015), in liver and fibroblasts from genetically modified mice 
(inducible SOD2 model) (Cox, McKay et al. 2018) and very recently in mice 
using radiation as a pro-oxidant agent (Zhang, Humes et al. 2018). 
Interestingly, nutrient restriction can lead to mitohormesis in adipocytes but 
treatment with antioxidants prevents this hormetic effect (Lettieri Barbato, 
Tatulli et al. 2015) (Figure 4). Thus, there are conflicting reports regarding 
the effects of antioxidant treatment also on mitohormesis. 
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Figure 4. Mitohormesis suggested mechanism of action. Ristow et al., published in 
Experimental gerolontogy (2010). 
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2 AIM 
The general aim of this thesis is to elucidate the effect of antioxidant 
supplementation on mitochondrial function in white and brown adipose 
tissue. 
The specific aims are: 
1. To delineate the role of ROS in chronic β3-AR activation-induced 
browning of white adipose tissue by the use of antioxidants as 
scavenging agents. 
2. To establish the pro-oxidative effect of antioxidants and their effect 
on mitochondrial function in white and brown adipocytes. 
3. To evaluate the effect of N-acetylcysteine supplementation on 
mitochondrial function of adipose tissue and whole-body 
metabolism. 
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3 METHODS 
In our studies, we have used a broad range of resources and analysis methods. 
We have performed in vitro and in vivo experiments, using C57BL/6J mice, 
primary cells and immortalized cell lines. We have studied functional 
processes with live cells and tissues, such as ROS production and cellular 
respiration. We have also analyzed cellular lipid and mitochondrial content in 
freshly dissected tissues. Moreover, we have analyzed the outcomes of the 
experiments in processed tissues and cells using commercially available kits 
to determine the levels of GSH, lactate, glycerol, free fatty acid (FFA) or 
insulin. These kits require tissue or cell processing to purify or concentrate 
samples for analysis. 
In this section, I will address the significant or controversial aspects of the 
most relevant methods and resources that I developed and used during this 
project. For descriptions of all methods, please read methods section of 
papers I and II. 
3T3-L1 adipocytes 
The murine 3T3-L1 cell line was established in 1974 and is a widely used in 
vitro adipocyte model that has been employed to study e.g. white adipocyte 
differentiation, lipid metabolism and endocrine function (Greenberger and 
Aaronson 1974). Untreated 3T3-L1 cells have fibroblast morphology and can 
be differentiated into lipid-storing adipocytes through a 10-day differentiation 
protocol. Their initial morphology i.e. multipolar and elongated shape is 
sequentially transformed into polygonal and rounded structure with 
multilocular lipid droplets (Figure 5). 
Figure 5. 3T3-L1 untreated (left) and after differentiation process (right). 
The differentiation protocol used in this project is essentially the same as 
described by Kohn and colleagues (Kohn, Summers et al. 1996). In brief, 
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addition of a differentiation cocktail containing insulin, dexamethasone and 
phosphodiesterase inhibitor, activates adipogenic processes resulting in the 
production of adipocyte-related proteins including the β3-AR (Komai, 
Musovic et al. 2016). Importantly, treatment of mature 3T3-L1 adipocytes 
with the β3-AR agonist CL316,243 induces a browning program as judged 
by upregulation of Prdm16, Pgc1α and Ucp1 (Duteil, Metzger et al. 2014). 
Thus, this model can be used to study, at least, some aspects of the browning 
process. 
The overall advantage of using an immortalized cell line as a model is its 
higher degree of reproducibility, i.e. its homogenous genotypic and 
phenotypic characteristics, compared to primary cells that typically show 
greater variability. On the other hand, during their immortalization process 
they might lose some characteristics that are key characteristics to the model 
of interest. 
Isolated primary adipocytes are non-attaching cells that are very fragile, and 
thus very difficult to handle and use in fluorescence microscopy or culture. 
Moreover, isolated adipocyte precursors, although being primary cells from 
the stromal vascular fraction, have to be differentiated ex vivo which gives 
them similar morphology as 3T3-L1 adipocytes and simultaneously also 
introduces an additional source of variability. 
Primary brown adipocytes 
Although there are several immortalized brown cell lines (Klaus, Choy et al. 
1994, Klein, Fasshauer et al. 2002), isolated and differentiated primary brown 
preadipocytes are more likely to resemble ‘real’ brown adipocytes and 
thereby we believe those cells are the better option to elucidate the 
mechanism for our observed effect of antioxidant treatment on brown adipose 
tissue in vivo. The method of isolation and culture of brown adipocytes was 
adapted from the method described by Néchad and colleagues (Néchad, 
Kuusela et al. 1983). Brown adipose tissue from young mice (younger than 4 
weeks), is required since there is a negative influence of age on the 
abundance of brown preadipocytes. Studies were performed in completely 
differentiated adipocytes (based on occurrence of multilocular lipid droplets) 
between days 8 and 9 from start of differentiation; only cultures in which >90 
% of cells displayed adipocyte morphology were used. 
Intracellular ROS generation in cultured adipocytes 
ROS are not one single entity but represent a broad range of chemically 
distinct oxidant molecules with different biological reactivity. One of the 
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most widely used tools to analyze ROS are fluorescent probes/dyes. They are 
reducing agents that become fluorescent when reacting with any oxidant 
molecule. Therefore, we cannot simply attribute their fluorescence to a 
specific reactive molecule but rather generalize the discussion to multiple 
ROS and speculate about the most probable substrate based on the probe 
cellular localization (Kalyanaraman, Darley-Usmar et al. 2012). However, 
probe-based fluorescence analyses together with measurements of cellular 
enzymes that possess well-established substrates facilitate the identification 
of the specific ROS compound that is most likely to be responsible for the 
ROS-associated fluorescence. The use of fluorescent probes for measuring 
ROS is complex since their nature as reducing agents interferes with cellular 
biochemistry in a dynamic manner. Their use requires therefore extensive 
titration to determine the minimum needed working concentrations (Polster, 
Nicholls et al. 2014), microscopy imaging to check cellular locations and 
distribution of fluorescent dyes and, most importantly, extra caution when 
drawing conclusions from measurements. Although other indirect methods 
could be used to estimate ROS levels, such as measurement of ROS-related 
damage e.g. protein oxidative modifications, it would be very difficult to 
determine the ROS origin and to follow changes in ROS production over 
time. Moreover, transiently increased ROS levels do not necessarily lead to 
measurable damage. Thus, we strongly believe that fluorescent probes, 
despite their complexity, are the best available option for ROS measurements 
in this project. 
CM-H2DCF-DA is a chloromethyl derivative of 2',7'-
dichlorodihydrofluorescein diacetate, a cellular probe that becomes 
fluorescent when it is oxidized by the loss of two electrons (Ex/Em: 495/520 
nm) in a two-step process. The chloromethyl presence provides better cellular 
retention of the probe. Indeed, this probe is commonly used to measure H2O2 
and other oxidants, or to monitor stimulation-induced changes in redox 
signaling in cultured cells (Wang, Si et al. 2010, Wojtala, Bonora et al. 
2014). Although this probe cannot identify specific oxidative species, it is - 
because of its homogeneous intracellular distribution through passive 
diffusion - a good indicator for the general ROS production. 
MitoSox Red, also called mito-hydroethidine or mito-dihydroethidium, is a 
fluorescent dye that measures O2
-•
 production in mitochondria (Ex/Em: 
520/580 nm). It is simply hydroethidine, a fluorescent probe, conjugated to 
triphenylphosphonium, which enables its accumulation in the mitochondrial 
matrix i.e. the positively charged MitoSox redistributes across the plasma and 
mitochondrial membranes according to its Nernst potential. Although some 
concerns about its subcellular location (Polster, Nicholls et al. 2014) and 
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reactivity with other oxidative species, it is considered suitable for measuring 
mitochondrial ROS, mostly O2
-•
, at least in normally polarized mitochondria 
(Kalyanaraman, Darley-Usmar et al. 2012). 
In order to quantify the effect of β3-AR stimulation on general ROS 
production, fluorescence images with laser scanning confocal microscopy 
(LSM 700 from Zeiss) were obtained at baseline followed by sequential 
measurements after addition of CL316,243 using different concentrations of 
CM-H2DCF-DA. After the minimum working concentration had been 
stablished, experiments in 12-well plates were performed and the total 
fluorescence level at every time point was quantified by calculating averages 
of 12-point readouts per well, covering the whole area of the well. 
Similarly, for titration and localization of MitoSox fluorescence together with 
the evaluation of the possibility of nuclear MitoSox staining, we used laser 
scanning confocal microscopy. The analysis of the resulting images, indicate 
that MitoSox nuclear-related fluorescence (Polster, Nicholls et al. 2014) is 
unlikely to contribute to the observed differences in the MitoSox 
measurements across groups. 
2-photon excitation fluorescence and coherent anti-Stokes Raman 
scattering microscopy 
Imaging lipids and mitochondria in freshly dissected tissues without any 
isolation or digestion is an extremely powerful tool that allows accurate 
measurements of cellular lipid content and mitochondrial density/activity. 
Coherent anti-Stokes Raman scattering microscopy (CARS) uses the inherent 
properties of stored lipids in cells, without any exogenous labeling. The 
specific vibration at 2845 cm
-1
 of carbon-hydrogen bonds in the alkylic 
chains of the highly dense triglycerides in lipid droplets is probed in a CARS 
process by overlapping two picosecond-pulsed laser beams at wavelengths 
817 nm and 1064 nm in the focal plane of an inverted optical microscope. 
Rhodamine 123 is a cationic fluorescent compound that binds specifically to 
mitochondria (Darzynkiewicz, Traganos et al. 1982) and displays fluorescent 
activity proportionally to the mitochondria’s membrane potential (Huang, 
Camara et al. 2007). It has an excitation wavelength that peaks at 505 nm and 
an emission wavelength at 560 nm. It can be excited with a laser emitting at 
817 nm following a 2-photon excitation (2-PE) process (Tehrani, Pendleton 
et al. 2017). By the use of an infrared wavelength laser, we reach more 
penetration in the sample together with reduced photobleaching. 
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A small piece of adipose tissue (<1 mm
3
) is collected from the same 
anatomical region in each animal and stained with Rhodamine 123. Indeed, 
taking adipose tissue pieces from the same region within a depot is critically 
important because of the heterogenic nature of adipose tissue. By means of 
dichroic mirrors and high optical-density filters, the forward-scattered CARS 
signal and backscattered 2-PE fluorescence signal are recorded using single 
photon counting detector technology. Multiple planes, each with 512x512 
pixels, are recorded resulting in 3D images of the tissues. Three different 
areas are recorded per sample. Quantitative data from the CARS and 2-PE 
fluorescence images are determined using ImageJ software. Regions of 
interest are defined by outlining the cell from autofluorescent images or by 
viewing z-stacks of the individual images. A voxel counting procedure is 
used to determine the number of voxels in the defined cell that meet a 
threshold intensity setting in the different analyzed channels (663 nm for 
CARS, 514 nm for Rhodamine 123) revealing cell size, lipid and 
mitochondrial content. In each image, 5 cells were analyzed. 
Gene expression analysis 
In order to quantify the messenger RNA (mRNA) expression levels of a gene, 
tissue or cells of interest were lysed and RNA was isolated using a 
commercial kit from Promega. When adipose tissue is processed, prior to 
isolation, an extra lipid elimination step is required. The concentration and 
quality of the isolated RNA was determined by absorbance measurement. 
Thereafter, the RNA was transcribed into complementary DNA (cDNA) 
generating the starting material for the quantitative real time polymerase 
chain reaction (qRT-PCR). Through continuous PCR cycles, a fluorescent 
(SYBR green)-tagged amplicon of the gene of interest was generated in a 
geometrical progression fashion, and its concentration was measured by a 
fluorometer. The threshold cycle, CT, indicates the fractional cycle number at 
which the amount of amplified target gene reaches a fixed threshold. It is 
inversely proportional to the expression of the target gene. For quantification 
purposes, there are two different methods: 
- Absolute quantification of a gene in the lysate can be 
calculated by interpolation of the readout in a 
calibration curve. This method is however not 
commonly used since accurate standard samples are 
required and it is usually unnecessary to know the 
absolute transcript copy number. 
- Relative quantification describes the change in 
expression of the target gene relative to either a 
standard sample (standard curve method) or the CT-
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value of a reference gene (comparative CT method) and 
then often relative to a reference group such as an 
untreated control or a sample at time zero in a time-
course study. 
In this work the comparative CT method was used and the gene-expression 
levels relative to untreated control were calculated using the 2
-∆∆CT 
formula 
(Livak and Schmittgen 2001). To use this method, two conditions need to be 
met: 
- Equal and high primer efficiency for all genes. To 
validate primer efficiency, a standard curve is created 
by serial dilutions (commonly 1:10) of a cDNA sample 
and qRT-PCR for each sample in duplicate is 
performed. Linear regression of results, allows 
calculating efficiency, which optimally should be 
found between 90 and 110 %. To keep constant 
efficiency across genes and samples one should also 
use the same transcription polymerase (in our case Fast 
SYBR-Green Master Mix) throughout the experiment. 
- Constitutive expression of the reference gene in all 
groups i.e. the expression should not be altered by the 
experimental conditions. Thus an equal amount of 
sample should, independently of the experimental 
group, result in the same CT value. 
Oxygen consumption rate 
One of the most informative analyses of mitochondrial function is 
quantification of cellular respiration, since it directly reflects electron 
transport chain performance/impairment and depends on many sequential 
reactions from glycolysis to oxidative phosphorylation. Oxygen consumption 
rate (OCR) is classically measured by the use of a Clark-type electrode, 
which is time-consuming, limited to whole cells or mitochondria in 
suspension and tied to manual injections of reagents (Yepez, Kremer et al. 
2018). The XF Seahorse instruments have, on the other hand, an integrated 
automatic drug delivery system and allow OCR measurements in several 
samples at the same time in a 24 or 96-well plate format. Samples can be 
either isolated mitochondria, cultured cells or even tissues. 
OCR analysis of isolated mitochondria provides useful information about 
their electron transport chain functionality without cellular interferences. In 
our case, we used succinate as the electron provider and rotenone to block 
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electron backflow to complex I to measure basal respiration of isolated 
mitochondria from adipose tissue. 
Cultured cells have the advantage of providing the machinery necessary for 
metabolizing and generating natural substrate to the mitochondria. By 
sequentially adding oligomycin (that blocks ATP synthase), FCCP (that 
uncouples mitochondria) and finally a mixture of antimycin A and rotenone 
(that completely stop electron flow through the transport chain) to plated 
cells, different mitochondrial characteristics can be calculated from the OCR 
data (Figure 6). 
Measurements of cellular respiration in white adipose tissue (Dunham-Snary, 
Sandel et al. 2014) allow mitochondrial status analysis without possible 
disturbances due to the cellular or mitochondrial isolation procedure. In our 
experimental conditions, the diffusion of drugs into the tissue pieces was 
however very heterogeneous. Thus, we could only with sufficient confidence 
record basal respiration while other mitochondrial parameters could not be 
accurately calculated. 
Seahorse is an extremely sensitive instrument that requires careful data 
analysis to remove non-responding wells or technical outliers. There can be 
significant variation between plates, i.e. a small variation in e.g. the amount 
of injected solutions and the quality of the starting material can lead to 
completely different absolute OCR values. To minimize this inter-plate 
effect, we therefore report ratios of OCR levels i.e. normalization to control 
OCR level and data are normalizing to the cell number for each well. As 
shown in Figure 6, basal respiration is calculated by subtracting the average 
of the last 3 measurements, which correspond to the non-mitochondrial 
respiration, to the average of the first 3 measurements. Then an average value 
is obtained for each group and finally values are normalized to a control 
group, thus obtaining a ratio. Statistical analyses are performed on these 
ratios.  
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Figure 6. Agilent Seahorse XF Cell Mito Stress test: (top) modulators of the 
electron transport chain are used to (bottom) calculate different respiration 
parameters that can be used to delineate the mitochondrial function of cultured 
cells, published by Agilent (2019). 
Body composition 
Dual-energy X-ray absorptiometry (DEXA) is a tool for determining body 
composition in vivo, providing measures of fat mass, bone-free lean tissue 
mass, total-body bone mineral, and total-bone mineral density. DEXA has 
been adapted to accurately measure body composition in anesthetized rodents 
by using specialized software in conjunction with clinical whole-body DEXA 
machines (Nagy and Clair 2000). It provides an accurate measurement on 
total body fat, but cannot accurately provide information about the fat 
distribution. Thus, other measurements such as weighing individual adipose 
depots and/or CT scans are necessary to fully draw conclusions about fat 
distribution. 
NAC treatment 
NAC has been used in therapeutic practices for more than 40 years. It was 
first used as a mucolytic agent, but soon new potential applications were 
found and nowadays it has more than 10 different clinical uses (Lasram, 
Dhouib et al. 2015) with a broad dosage range. Moreover, it has been studied 
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in many different conditions e.g. fatigue reducing agent in sports (Petersen, 
McKenna et al. 2012) or type-2 diabetes (Ho, Chen et al. 1999), and in 
different models i.e. cell lines (Liu, Liu et al. 2017), C. Elegans (Oh, Park et 
al. 2015), rodents (El Midaoui, Ismael et al. 2008) and humans (Kleinveld, 
Demacker et al. 1992). In in vivo use, different administration ways are 
reported e.g. intraperitoneal injection (IP) (Wright, Renoir et al. 2015), 
supplementation of drinking water (Ma, Gao et al. 2016), food 
supplementation (Ikonne, Vann et al. 2019) or tablets (Fulghesu, Ciampelli et 
al. 2002). In rodents, it is usually administered through drinking water, with 
doses going from 1 g/L (Jang and Sharkis 2007) to 20 g/L (Pinniger, Terrill 
et al. 2017). In in vitro models, the concentration range of NAC used is quite 
broad: from 5 µM (Calzadilla, Sapochnik et al. 2011), up to 20 mM (Toyoda, 
Hayashi et al. 2004). However, 1 mM is one of the most commonly used 
concentrations, and this concentration of NAC has proven to effectively 
scavenge ROS (Inoguchi, Li et al. 2000, Maheshwari, Misro et al. 2011, Ali, 
Qadir et al. 2017). Therefore, we decided to use 1 mM NAC in our in vitro 
experiments. 
In paper I, our initial aim was to study the role of ROS in adipose tissue 
browning in mice and to use NAC as our primary antioxidant. Thus, to start 
on the most conservative side to avoid potential deleterious effects that were 
reported with higher doses (>6.5 g/L), we picked the lowest reported dose (1 
g/L in drinking water) and short pretreatment (1 week) (Palmer, Doctor et al. 
2007, Sceneay, Liu et al. 2013). NAC supplementation was continued during 
the 10-day β3-AR stimulation period, but the total NAC exposure was still on 
the lower side compared to the majority of published studies. In paper II, our 
objective was to explore different doses and treatment length to evaluate the 
impact of both these factors on mitochondrial function in adipose tissue. We 
decided to use a very low dose, 0.5 g/L, which to our knowledge has not been 
tested in previously published studies, a middle range dose, 2 g/L, shown to 
be protective against high fat diet (HFD)-induced metabolic disorders (Ma, 
Gao et al. 2016) and a high dose, 10 g/L, reported to have deleterious effects 
(Palmer, Doctor et al. 2007). 
Statistical analysis 
GraphPad Prism 8 (GraphPad Software, San Diego, CA) was used for 
statistical analysis. Results in this thesis are represented as mean values ± 
SEM, expressed either as fold-change relative to controls or as absolute 
values. Comparisons were performed using one-way analysis of variance, 
two-way analysis of variance, or two-tailed Student’s t test depending on the 
experimental layout. Data were log-transformed as necessary to achieve 
normal distributions; and p<0.05 was considered significant. 
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4 RESULTS AND DISCUSSION 
Antioxidant treatment induces reductive stress associated 
with mitochondrial dysfunction in adipocytes (Paper I) 
Browning is a process that can be triggered by β3-AR activation leading to 
the conversion of white adipocytes into beige adipocytes which have 
increased mitochondrial content and express higher levels of UCP1 
(Nedergaard and Cannon 2014). Treatment of adipocytes with CL316,243, a 
potent and selective β3-AR agonist (Bloom, Dutia et al. 1992, Yoshida, 
Sakane et al. 1994, Li, Zhu et al. 2005), increases the intracellular levels of 
cyclic AMP, driving activation of the PKA complex leading to hormone-
sensitive lipase phosphorylation (activation) and thereby the breakdown of 
triglycerides to FFAs and glycerol, i.e. lipolysis (Arner and Langin 2007). 
Elevated fatty acid levels increase the ROS production from non-
mitochondrial sources such as NADPH oxidases in adipocytes (Han, 
Umemoto et al. 2012). Furthermore, β-adrenergic stimulation promotes 
OXPHOS in adipocytes (Duteil, Metzger et al. 2014) and consequentially 
mitochondrial ROS, as a by-product of oxidative metabolism, will also 
increase. We thus argue that β3-AR stimulation will, at least transiently, 
increase ROS levels in adipocytes. NAC is an antioxidant that can scavenge 
ROS both directly and indirectly as a precursor of glutathione (Kelly 1998, 
Mokhtari, Afsharian et al. 2017). Vitamin E, similarly, can directly scavenge 
oxidant radicals and alter redox status of the cell, i.e. glutathione cellular 
levels (Packer, Weber et al. 2001). Altogether, we hypothesize that such 
increase in ROS stimulates signaling pathways that trigger β3-AR activation-
induced adipose tissue browning and consequently pretreatment with NAC 
and vitamin E should reduce the browning response. 
ANTIOXIDANT EFFECTS IN 3T3-L1 ADIPOCYTES 
NAC and vitamin E alter glutathione levels in 3T3-L1 adipocytes 
To investigate the effect of antioxidant treatment in adipocytes’ redox status, 
we treated 3T3-L1 adipocytes with different antioxidants. As shown in 
Figure 7, NAC and glutathione ethyl ester raised the levels of reduced 
glutathione by respectively, 20 and 10 %, shifting the redox balance towards 
a more reduced status. Interestingly, vitamin E treatment increased GSH to 
similar levels of direct glutathione ester treatment. NAC treatment has been 
shown to increase systemic GSH levels mainly through hepatic GSH 
synthesis (Atkuri, Mantovani et al. 2007), but here we thus demonstrate that 
adipocytes also increase their GSH levels in response to NAC treatment. 
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Similarly, vitamin E treatment has been shown to increase GSH levels in 
erythrocytes in patients (Jain, McVie et al. 2000) and in liver in rats (Scott, 
Kelleher et al. 1977), but the mechanism of this upregulation has not been 
established. Our results indicate that vitamin E affects the redox status of 
adipocytes directly, and increase the GSH levels in adipocyte to a similar 
extent as Scoot and colleagues reported for liver and kidney. 
Figure 7. (left) Relative GSH and (right) GSSG levels in 3T3-L13 adipocytes treated 
with or without NAC, glutathione ethyl ester and vitamin E for 48 h. (n=4/group, 
*p<0.05, **p<0.01 and ****p<0.0001). 
The absolute levels of GSSG are at least 10 times lower than the GSH levels 
in 3T3-L1 adipocytes and are calculated from measurements of total 
glutathione and GSH (page 2349 in Paper I: Experimental procedures; 
Measurements of GSH and GSSG). We believe that these facts, combined 
with the reduced accuracy when estimating GSSG levels that are as low as 
we observe, make the ratio calculations very unreliable (SD in GSSG are 5 to 
7 times larger than in GSH levels). A slight variation in glutathione and GSH 
readouts during the analysis (optical density measurement) could thus easily 
have a strong impact of the estimated GSSG level and thereby lead to a 
misleading GSH/GSSG ratio. For this reason, we did not report the 
GSH/GSSG ratios. Rather our main conclusion is that the increase in GSH 
levels drives a change in the cells’ redox state since GSSG levels do not 
change (except for vitamin E). In fact, even though GSH levels increase in all 
antioxidant treated groups only vitamin E generates a significant change in 
the calculated ratio, and this is surprisingly a decrease. 
β3-AR activation has no effect on glutathione levels in 3T3-L1 adipocytes  
β3-AR stimulation of cultured adipocytes had no effect on the intracellular 
GSH or GSSG levels (Figure 8). This indicates that either adipocytes rapidly 
restore their GSH levels (that might have been decreased due to ROS 
generated by NADPH oxidases and/or from mitochondrial sources) or 
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changes in GSH are too small to be detected by this method. Surprisingly, 
when NAC-pretreated cells are stimulated with CL316,243, GSH levels are 
similar to the levels of untreated cells. From these data, we can infer that both 
compounds can interact, resulting in decreased GSH levels, either by an 
elevation of ROS levels or interference in GSH production. 
Figure 8.  (left) Relative GSH and (right) GSSG levels in cultured adipocytes 
treated with vehicle or 1 mM NAC for 48 h exposed to 1 µM CL316,243 or vehicle 
for. (n=4/group, *p<0.05). 
β3-AR activation increases ROS and Ucp1 production in 3T3-L1 adipocytes 
To confirm that the expected CL316,243-induced browning response is in 
place in our 3T3-L1 adipocytes, we analyzed Ucp1 mRNA expression. 
Indeed, CL316,243 treatment led to increased Ucp1 levels. However, 
contrary to our hypothesis, NAC pretreatment had no effect on Ucp1 
expression as shown in Figure 9. 
Figure 9. Ucp1 expression in cultured adipocytes pretreated with or without 1 
mM NAC for 24 h after 60’ incubation with 1µM CL316,243. (n=6/group). 
Palmitate can stimulate NADPH oxidase 4 (NOX4)-derived ROS production 
in adipocytes (Han, Umemoto et al. 2012). To elucidate the possibility of a 
similar effect through β3-AR-induced lipolysis, we measured transient effects 
on the ROS production in 3T3-L1-derived adipocytes using CM-H2DCF-DA 
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for 60 minutes. The ROS production increased 3-fold with adrenergic 
induction but, surprisingly, NAC pretreatment did not show any effect on the 
total ROS production in these lipolytic cells (Figure 10). 
Figure 10. (left) Representative ROS emission images (CM-H2DCF-DA) of cultured 
adipocytes before and 45’ after incubation with 5 µM CL316,243 and (right) 
quantification of the ROS emission of cultured adipocytes pretreated with or without 
1 mM NAC for 24 h after 60’ incubation with 1 µM CL316,243. (n=3/group, 
experiment repeated three times, **p<0.01). 
Next, we decided to selectively analyze the mitochondrial ROS production to 
investigate whether there is an effect of NAC treatment on the mitochondrial 
GSH pool leading to reduced ROS levels locally (that would not be picked up 
by measuring the total ROS levels by CM-H2DCF-DA). Indeed, it surely was 
an effect by NAC treatment, but rather than seeing a decrease, NAC 
increased the mitochondrial ROS production in CL316,243-stimulated cells. 
While this result may appear surprising, it has been previously reported that 
increased GSH levels can lead to a too reduced state in the mitochondria that 
increases the ROS production through reduction of oxygen to superoxide 
anion (Korge, Calmettes et al. 2015). Moreover. since ROS has been shown 
to inhibit respiration in adipocytes (Wang, Si et al. 2010), we analyzed the 
oxygen consumption and the glycolytic activity (lactate production) in NAC 
pretreated cells with and without CL316,243 stimulation. We found reduced 
oxygen consumption rate (OCR) and increased lactate production in NAC-
treated cells independently of adrenergic stimuli (Figure 11). Through 
analysis of the OCR in response to oligomycin, we found that this NAC-
induced decrease in respiration is not due to reduced uncoupled respiration 
but rather is an effect from reduced oxidative phosphorylation. 
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Figure 11. (top) Area under the curve (AUC) quantification of MitoSox Red 
fluorescence of cultured adipocytes pretreated with or without 1 mM NAC for 24 h, 
30’ after incubation with 5 µM CL316,243. (n=3/group, **p<0.01). (bottom-left) 
Lactate levels in medium from cultured adipocytes incubated for 24 h with or without 
1 mM NAC in combination with CL316,243 (n=3/group, *p<0.05). (bottom-right) 
Oxygen consumption rate of cultured adipocytes treated in presence or absence of 1 
mM NAC for 48 h and thereafter exposed to 1 µM CL316,243 or vehicle during 20’ 
(n=12/group, ****p<0.0001). 
There were no morphological changes or signs of cell death through visual 
inspection indicating that the reduced respiration in NAC-treated cells is a 
successful adaptation that limits the buildup of too high mitochondrial ROS 
levels. However, Wang et al. shows that shorter-term NAC treatment actually 
can scavenge ROS and this effect is associated with increased oxygen 
consumption. To elucidate this discrepancy, we analyzed basal OCR in 3T3-
L1 adipocytes with different NAC concentrations during 30 minutes and a 
fixed dose for 24 and 48 h. Interestingly, the adipocytes display a completely 
opposite behavior depending on the exposure time. Short-time exposure leads 
to an increase in OCR i.e. under this condition NAC is likely acting as a ROS 
scavenger, leading to increased respiration (Figure 12).  
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Figure 12. (left) OCR of cultured adipocytes 30’ after NAC treatment, at indicated 
concentrations (n=10/group, ****p<0.0001). (center) OCR of cultured adipocytes 
treated with 1 mM NAC or 10 µM vitamin E (n=12/group, *p<0.05, ****p<0.0001). 
(right) NRF2 protein levels in cultured adipocytes treated with 1 mM NAC at the 
indicated time points (n=4/group, *p<0.05). 
Longer-term treatment (≥ 24 h) with NAC, on the other hand, resulted in 
reduced cellular respiration most probably due to a compensatory response to 
put a lid on the rising mitochondrial ROS levels. In line with this assumption, 
NAC treatment leads to activation of the Kelch-like ECH-associated protein 
1 (KEAP1)/Nuclear factor erythroid 2-related factor 2 (NRF2) pathway, a 
protective mechanism triggered by increased ROS-levels (Ma 2013), 
resulting in elevated levels of NRF2 protein (Figure 12) that in turn induce 
increased expression of cytoprotective proteins. 
The difference between short- and long-term effects of NAC could be 
explained on the basis of NAC acting as an antioxidant, scavenging ROS in 
the acute exposure setting but triggering reductive stress i.e. increased ROS 
production, due to increased mitochondrial GSH levels, and thus reduced 
oxygen consumption and activation of the KEAP1/NRF2 pathway when 
treatment is prolonged. 
Vitamin E effects in 3T3-L1 adipocytes 
Vitamin E is a member, together with vitamin C and thiols (e.g. glutathione), 
of the so called antioxidant protective network of the cell, as shown in Figure 
13 (Packer, Weber et al. 2001).  
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Figure 13. The antioxidant network showing the interaction among vitamin E, 
vitamin C and thiol redox cycles. Packer et al., published by The Journal of Nutrition 
(2001). 
Vitamin E had similar consequences in cultured adipocytes as NAC although 
to a lesser extent i.e. vitamin E increased glutathione levels (as shown in 
Figure 7), that further increased β3-AR stimulation-induced mitochondrial 
ROS production associated with reduced OCR. Interestingly, vitamin E 
treatment at a lower dose (1 µM) than we used, has been shown to have no 
impact in mitochondrial function in murine mesangial cells, but when 
conjugated to TPP
+
 to specifically target mitochondria, it reduces oxygen 
consumption by 30 % due to reduced oxidative phosphorylation associated 
with increased glycolysis (Reily, Mitchell et al. 2013). Thus, we propose that 
the higher vitamin E concentration and treatment duration in our adipocyte 
studies could lead to sufficient mitochondrial vitamin E accumulation to 
cause a negative impact on oxygen consumption. Considering the 
interconnection between vitamin E and the thiols in the antioxidant network, 
we hypothesize that treatment with vitamin E, through increased GSH 
mitochondrial levels, leads to similar consequences as treatment with NAC 
i.e. reduced basal OCR and increased mitochondrial ROS production. 
To summarize this section, β3-AR activation in 3T3-L1 adipocytes leads to 
an increase in ROS and Ucp1 expression, but 24 h antioxidant pretreatment 
does not prevent these effects. Furthermore, this NAC preconditioning of 
adipocytes increases the mitochondrial ROS levels associated with reduced 
oxygen consumption and elevated glycolysis. In conclusion, exogenous 
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antioxidants can, at least in adipocytes, lead to increased mitochondrial ROS 
production, likely through an elevation of mitochondrial GSH levels; 
therefore, they cannot be used as a tool to study the role of ROS in β3-AR 
activation-induced browning of adipose tissue. 
ANTIOXIDANT EFFECTS IN MOUSE ADIPOSE TISSUE 
NAC treatment leads to impaired fatty acid clearance in mice 
To elucidate whether the observed effect of antioxidants on mitochondrial 
ROS production in vitro could translate into a disturbance of the browning 
process in vivo, we treated mice with either regular or NAC-supplemented 
drinking water for a week. Then, we injected animals for 10 days with either 
vehicle or CL316,243 to induce browning of IWAT. Tissues and samples 
were collected at 3 h, 24 h and 10 days (daily injection) post injection. 
At all timepoints, no differences in total body weight across the four groups 
were observed. Furthermore, there were no differences in body weight-
normalized weight of IWAT, GWAT or BAT between animals injected with 
CL316,243 on regular and NAC-supplemented water. Relative gene 
expression analysis of browning markers in the collected adipose tissues, 
showed no effect of NAC treatment in CL316,243 injected animals after 3 
and 24 h. These data suggest that our antioxidant treatment regimen does not 
interfere with the acute browning response. 
Short-term NAC treatment (1.5 hours) has been shown to reduce ROS and 
lipolysis in cultured human adipocytes (Krawczyk, Haller et al. 2012). To test 
whether lipolysis is affected by antioxidant treatment in our experimental 
setting, mice were treated for a week with water or NAC and further injected 
with either vehicle or CL316,243. NAC had no effect on serum glycerol 
levels, neither in vehicle nor β3-AR-stimulated mice (Figure 14). 
Interestingly, serum FFA levels of NAC-treated mice were significantly 
higher compared to control animals receiving regular water. Thus lipolysis, 
as judged by glycerol levels, was not influenced by NAC treatment. 
However, the higher FFA levels suggest reduced fatty acid clearance, which - 
given our in vitro data - points towards a reduced mitochondrial metabolism 
in NAC-treated mice. 
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Figure 14. (left) Quantification, of a 60-minute time course, of glycerol and (right) 
FFA levels in serum of mice pretreated for 1 week with either water or NAC 1 g/L 
solution injected with either vehicle or 1 µg of CL316,243 per g of body weight and 
area under the curve (AUC) (n=5/group, ****p<0.0001, ≠p<0.0001). 
NAC treatment reduces browning of IWAT 
After 10 days of daily CL316,243 treatment (i.e. 2.5 weeks of antioxidant 
treatment), NAC reduced the CL316,243-induced mRNA and protein 
expression of several browning and mitochondrial markers in IWAT (Ucp1, 
Pgc1α, Cytochrome c oxidase subunit 4 isoform 1 (CoxIV) and 
mitochondrially encoded ATP synthase membrane subunit 6 (Atp6). 
Furthermore, the COXIV protein expression was reduced in NAC-treated 
mice even in absence of β3-AR activation (Figure 15). These data are thus 
consistent with mitochondrial dysfunction in white adipose tissue of NAC-
treated mice. 
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Figure 15. (top) Relative mRNA expression of Ucp1, Pgc1α, CoxIV and Atp6  in 
IWAT in response to the different treatment regimens in C57/BL6J mice, 
(n=10/group, *p<0.05, **p<0.01). (bottom-left) Relative UCP1 and (bottom-right) 
COXIV protein expression in IWAT (n=5/group, *p<0.05, **p<0.01 ****p<0.0001). 
To further explore the effect of NAC on adipocyte mitochondrial function, 
we analyzed lipid and mitochondrial density in freshly dissected mouse 
IWAT samples using combined CARS and 2-PE fluorescence microscopy. 
Stimulation of β-ARs in IWAT is typically associated with a reduction in 
lipid density (Granneman, Li et al. 2005) combined with increased number of 
mitochondria per cell (Barneda, Frontini et al. 2013). Through image 
analysis, both these effects could be observed in CL316,243-treated animals, 
but NAC preconditioning blunted this reduction in lipid density and 
mitochondrial increased density/activity (Figure 16). The CL316,243-induced 
difference in mitochondrial density/activity was significant between groups 
also when mitochondrial density/activity were analyzed as absolute areas, 
while the lipid density area was no longer different between groups arguing 
that reduced mitochondrial density/activity is the primary mechanism 
underlying the blunted IWAT browning in NAC-treated mice. 
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Figure 16. (top) Representative images of fresh pieces of IWAT of C57/BL6J mice 
pretreated for 1 week with either water or NAC 1 g/L solution followed by 10 days 
injection with either vehicle or 1 µg of CL316,243 per g of body weight of CARS 
(lipids, in purple) and 2-PE fluorescence microscopy (mitochondria, in green). 
(middle) Relative and (bottom) absolute quantification of (left) lipid content and 
(right) mitochondrial density/activity in experiments depicted (n=5/group, *p<0.05, 
**p<0.01). 
The average adipocyte size did not differ between groups, but there was 
considerable variability in cell size leading to larger variability in lipid 
density and mitochondrial density/activity when these parameters are 
analyzed as absolute area as opposed to % of cell area. No changes in 
morphology of lipid droplets could be observed in cells treated with NAC 
alone, neither with regard to total density nor number of droplets per cell 
(data not shown). 
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Another interesting consequence of NAC treatment in white adipose tissue 
was the increase in relative IWAT and GWAT weights (normalized to body 
weight (Figure 17). Oxidative stress has been shown to contribute to an 
upregulation of phosphoenolpyruvate carboxykinase (PEPCK) in hepatocytes 
(Ito, Oumi et al. 2006). Indeed, Pepck, the rate-limiting enzyme for 
glyceroneogenesis and essential for re-esterification of fatty acids in adipose 
tissue (Hanson and Reshef 2003), was increased 3.5-fold by NAC treatment 
in IWAT. This increase in Pepck may at least in part explain the increased fat 
pad weight in NAC-treated control animals and could also be regarded as a 
secondary adaptation to reduce the risk of the lipotoxic effects from increased 
circulating fatty acid levels. 
We suggest that NAC-induced mitochondrial reductive stress in IWAT (as 
we demonstrated in 3T3-L1 adipocytes) interferes with both the components 
necessary to accomplish a complete β3-AR activation-induced browning 
response and the systemic FFA clearance, resulting in an increased FFA 
reuptake by WAT. 
Figure 17. (left) IWAT, GWAT and BAT weight (normalized to total body weight) in 
response to the different treatment regimens in C57/BL6J mice (n=10/group, 
*p<0.05, **p<0.01). (right) Relative Pepck levels in IWAT 10 days after CL316,243 
treatment (n=10/group, ***p<0.001). 
Effect of vitamin E treatment on IWAT browning 
To study whether the observed effect on white adipose tissue browning in 
NAC-treated mice could be reproduced with other antioxidant that also has 
an effect in glutathione levels, we investigated the effect of vitamin E 
treatment on CL316,243-induced browning in mice. 
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Figure 18. (left) IWAT, GWAT and BAT weight, normalized to total body weight, in 
response to the different treatment regimens in C57/BL6J mice (n=10/group). (right) 
Relative mRNA expression of Ucp1, Pgc1α, CoxIV, and Atp6 in IWAT, post chronic 
CL316,243 treatment (n=10/group, *p<0.05, **p<0.01). 
Vitamin E-treated mice did not show an increase in fat pad weights and no 
significant effect on Ucp1 and Pgc1α mRNA expression in IWAT (Figure 
18). However, vitamin E treatment reduced the CL316,243-induced 
expression of the mitochondrial markers Atp6 and CoxIV in IWAT. Thus, 
similarly to what we observed in vitro, vitamin E has a weaker effect on a 
white adipose tissue compared to NAC in this regard. Thus, both NAC and 
vitamin E interfered with CL316,243-induced mitochondrial changes, but 
NAC had a more potent effect than vitamin E. We hypothesize that the 
indirect effect of vitamin E treatment on mitochondrial glutathione levels, as 
we showed previously in 3T3-L1 cells, is not strong enough to exert 
sufficient reductive stress to cause the same negative impact as NAC 
treatment in adipose tissue. 
NAC treatment induces mitochondrial dysfunction in BAT 
NAC treatment had no effect on body weight-normalized BAT weight either 
in controls or in CL316,243 injected animals (Figure 19). Although no 
differences could be observed in Upc1 and Pgc1α mRNA levels, UCP1 
protein levels were upregulated in BAT of CL316,243 treated animals in line 
with previous studies (Park, Jung et al. 2015, Xiao, Goldgof et al. 2015). 
Importantly, this upregulation was slightly blunted in NAC-treated animals 
(Figure 19). Furthermore, NAC treatment blunted the CL316,243-induced 
increase in Atp6 and CoxIV mRNA levels in BAT. This effect on CoxIV 
mRNA expression was however not observed at the protein level. 
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Figure 19. (top) Relative mRNA expression of Ucp1, Pgc1α, CoxIV, and Atp6 in BAT 
in response to the different treatment regimens in C57/BL6J mice, (n=10/group, 
*p<0.05, **p<0.01). (bottom-left) Relative UCP1 and (bottom-right) COXIV protein 
expression in IWAT (n=5/group, *p<0.05). 
Moreover, NAC completely suppressed the CL316,243-induced reduction in 
lipid density and, even in the absence of CL316,243 stimulation, reduced the 
mitochondrial density/activity of freshly dissected BAT as judged by 
combined CARS and fluorescence microscopy (Figure 20). 
The difference in mitochondrial density/activity between NAC and their 
corresponding controls remained significant in CL316,243 treated mice even 
if when measured as absolute area. Similar to IWAT, lipid density measured 
as absolute area/cell and average brown adipocyte size did not differ between 
groups suggesting that the NAC-induced difference in mitochondrial 
density/activity is the primary driver of the observed BAT phenotype. 
Rhodamine 123 is a probe that is commonly used to locate mitochondria by 
fluorescence microscopy (Johnson, Walsh et al. 1980), but can also be used 
to monitor the membrane potential of mitochondria (Baracca, Sgarbi et al. 
2003), i.e. mitochondrial activity. The reduced Rhodamine 123 staining of 
freshly dissected BAT samples in NAC-treated mice may thus be due to both 
reduced mitochondrial density and blunted activity. However, measurements 
of the relative protein levels of four OXPHOS complexes in BAT showed no 
differences across the four groups thus arguing that it is the mitochondrial 
activity rather than the density that is affected. Activation of β3-ARs has 
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been shown to increase free fatty acid uptake and utilization in BAT in vivo 
(Warner, Kjellstedt et al. 2016). We thus suggest that these data provide a 
plausible explanation for the elevated CL316,243-induced FFAs levels in 
NAC-treated mice. 
Figure 20. (top) Representative images of fresh pieces of BAT of C57/BL6J mice 
pretreated for 1 week with either water or NAC 1 g/L solution followed by 10 days 
injection with either vehicle or 1 µg of CL316,243 per g of body weight of CARS 
(lipids, in purple) and 2-PE fluorescence microscopy (mitochondria, in green). 
(middle) Relative and (bottom) absolute quantification of (left) lipid content and 
(right) mitochondrial density/activity in experiments depicted (n=5/group, *p<0.05, 
**p<0.01). 
Data obtained from studies of 3T3-L1 adipocytes do not necessarily reflect 
the functionality of brown adipocytes. To further investigate the NAC-
mediated mitochondrial dysfunction in brown adipocytes, we therefore 
Adipose tissue mitochondrial function is modulated by antioxidants 
40 
isolated and differentiated primary brown preadipocytes into mature brown 
adipocytes in vitro. In this model of brown adipocytes, NAC treatment 
reduced basal respiration, uncoupled respiration, ATP-production linked 
respiration and spare respiratory capacity independently of adrenergic 
activation as judged by oxygen consumption rate analysis (Figure 21). 
Figure 21. (top) OCR of primary brown cultured adipocytes treated with 1 mM NAC 
for 48 h and 1 µM CL316,243 for 24 h analyzed using the Seahorse Technology; 
cells were sequentially treated (dashed lines show addition points) with 1 µM 
Oligomycin, 0.6 µM FCCP, and 0.5 µM Rotenone plus Antimycin A to assess 
mitochondrial function and (middle and bottom) calculate its main parameters 
(n=14/group, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). 
In conclusion, we believe that 1) the reduction in FFA clearance in NAC-
treated mice, 2) the reduction in mitochondrial activity in BAT as judged by 
fluorescence microscopy in tissues, and 3) the reduction in oxygen 
consumption in cultured NAC-treated brown adipocytes, demonstrates that 
our chronic NAC treatment regimen leads to mitochondrial dysfunction in 
BAT.  
Eduard Peris Franquet 
41 
NAC supplementation leads to reductive stress in mouse adipose tissue 
Increased cellular ROS levels activate the NRF2/KEAP1 pathway, leading to 
increased levels of NRF2 (Bryan, Olayanju et al. 2013). This pathway 
stimulates the production of PRDXs (Miyamoto, Izumi et al. 2011) and 
SODs (Sun, Ren et al. 2015) that protect the cells from oxidative damage. 
IWAT Sod2 mRNA levels were upregulated in mice receiving both NAC and 
CL316,243 compared to their controls. Moreover, NAC-treated animals, 
independently of adrenergic activation, displayed significant upregulation of 
SOD2 protein expression levels compared to their controls. Similarly, but 
more dramatically, IWAT PRDX3 levels were also upregulated (Figure 22). 
Interestingly PRDX2, another peroxiredoxin enriched in the cytosol is 
equally expressed by all groups (Figure 22). In line with our ROS 
measurements in 3T3-L1 adipocytes, these PRDX data suggest that the 
increased reductive stress of IWAT in NAC-treated mice is localized to the 
mitochondria. 
Figure 22. (top-left) IWAT and BAT Sod2 mRNA expression after 10-day treatment 
with CL316,243 in C57/BL6J mice on either NAC-supplemented or regular water 
(n=5/group, **p<0.01). (top-right) SOD2, (bottom-left) PRDX3, and (bottom-right) 
PRDX2 protein levels in IWAT after 10-day treatment with CL316,243 in C57/BL6J 
mice on either NAC-supplemented or regular water (n=5/group, *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001. 
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Thus, NAC, although being antioxidant, upregulates the production of 
mitochondrial enzymes that are responsible to scavenge superoxide anion and 
hydrogen peroxide, i.e. signs of increased oxidative stress. This pro-oxidant 
behavior of antioxidants may appear surprising, but it is well in line with a 
previous myoblast study where NAC treatment, especially at low ROS levels, 
leads to an alteration of the GSH homeostasis resulting in mitochondrial 
oxidation (Zhang, Limphong et al. 2012). The alteration of GSH homeostasis 
has been linked to chemical reduction of oxygen to superoxide anion, 
resulting in increased ROS levels, in a process referred to as reductive stress, 
in opposition to oxidative stress (Korge, Calmettes et al. 2015) although the 
outcome in both is elevated ROS production with similar consequences. 
Oxidative stress is linked to increased mitochondrial fission (Ježek, Cooper et 
al. 2018), and reductive stress has been shown to increase the unfolded 
protein response in the endoplasmic reticulum. Under our experimental 
conditions, we could however not detect any effects of NAC treatment on 
either mitochondrial fission/fusion related genes expression or changes in 
Xbp1 mRNA expression, a marker of endoplasmic reticulum stress (Wang 
and Kaufman 2016). One possibility is that we fail to observe such 
phenomena due to the transient nature of transcriptional regulation. 
CONCLUDING REMARKS ON PAPER I 
Our adipose tissue data confirms the occurrence of reductive stress in 
antioxidant-treated mice likely due to increased GSH levels in adipocytes, 
driving the reduction of molecular oxygen to superoxide in the adipocytes’ 
mitochondria, i.e. elevation in ROS production. The adipocytes adapt to this 
pro-oxidant effect of chronic antioxidant treatment by activating the 
NRF2/KEAP1 pathway and reducing their mitochondrial oxidative 
metabolism as evident from e.g. the blunted β3-AR-activation induced 
browning of IWAT (Figure 23). 
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Figure 23. Model of antioxidant and β3-AR agonist effects on ROS and 
mitochondrial activity in adipocytes. 
  
Adipose tissue mitochondrial function is modulated by antioxidants 
44 
Prolonged N-acetylcysteine treatment induces 
mitohormesis in adipose tissue (Paper II) 
Antioxidants are commonly used for their potential to fight oxidative stress in 
conditions where imbalance in ROS production and neutralization plays a 
central role. In vitro studies of myocytes (Singh, Charles et al. 2015) and 
tumor cells (Sceneay, Liu et al. 2013), or in vivo (Fulghesu, Ciampelli et al. 
2002, Palmer, Doctor et al. 2007, Wright, Renoir et al. 2015, Ma, Gao et al. 
2016, Pinniger, Terrill et al. 2017) in mice and humans have investigated the 
effects of NAC treatment using a broad range of concentrations and 
durations, from 2 weeks to 4 months, describing both beneficial results (e.g. 
protection against HFD-induced obesity, improvement of insulin sensitivity 
in women with polycystic ovarian syndrome or protection against 
neurological diseases) and deleterious effects (mitochondrial dysfunction, 
increased metastasis or reduced growth). 
Temporary elevation of mitochondrial ROS levels (Lettieri Barbato, Tatulli et 
al. 2015, Zhang, Humes et al. 2018) or SOD2 levels (Yang and Hekimi 2010) 
trigger a coordinated response leaving the cell less susceptible to subsequent 
perturbations. We thus hypothesize that NAC treatment, although causing 
reduced mitochondrial function (as shown in paper I), also has the potential 
to enhance mitochondrial function in adipocytes in mice through 
mitohormesis. We also hypothesize that such hormetic effect of NAC is dose-
dependent. Based on reports from previous studies, we chose three different 
concentrations of NAC in drinking water to cover a broad range of doses: 
- Low dose, 0.5 g/L in drinking water, which is half of 
the dose used in the majority of mouse studies. 
- Middle range dose, 2 g/L in drinking water, used e.g. 
in a study on HFD-fed mice and was shown to reduce 
weight gain (Ma, Gao et al. 2016). 
- High dose, 10 g/L in drinking water to study the 
possibility of aberrant side-effects. 
Based on the analysis of published studies, we wanted to follow NAC-
treatment effects from relatively short (2 and 4 weeks) and chronic exposure 
(16 weeks). 
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SHORT-TERM NAC TREATMENT EFFECTS 
2-week high dose NAC treatment leads to reduced weight gain and reduced 
mitochondrial function in BAT  
Mice treated with the highest NAC dose (10 g/L) showed a 7.8 % lower body 
weight than controls after 2 weeks of treatment as shown in Figure 24. This 
effect was due to reduced weight gain, not detected in the lower dose groups. 
Body composition determined by DEXA revealed no differences in body fat 
percentage or bone mass. Body length was not different between control and 
NAC treated mice. Interestingly, the absolute lean mass was however lower 
in the 10 g/L NAC-group than in controls. 
Figure 24. (left) Total body weight and fat percentage of C57BL/6J mice treated for 
2 weeks with either water or NAC 10 g/L solution (n=5/group, *p<0.05). (right) 
Fasting glucose and insulin levels of mice treated with either water or NAC 10 g/L 
solution (n=5/group). 
Short-term NAC treatment can lead to reductive stress in myoblasts (Singh, 
Charles et al. 2015). Moreover, ROS can reduce lean body mass by 
stimulating the expression and activity of skeletal muscle protein degradation 
pathways (Abrigo, Elorza et al. 2018). Thus, the observed reduction in 
absolute lean mass in the 10 g/L NAC-group could be attributed to reductive 
stress in muscle. 
To further study the pro-oxidant effect of NAC in adipocytes that we 
established in paper I, we analyzed the functionality of isolated mitochondria 
from BAT of mice treated with 10 g/L of NAC for 2 weeks and their 
controls. There was a significant reduction of BAT mitochondrial OCR in 
NAC treated animals that we interpret as a sign of reductive stress. 
Mitochondrial oxidants have been shown to cause insulin resistance 
impairing the Glucose Transporter type 4 (GLUT4) localization to GLUT4 
storage vesicles without changes in the oxidative phosphorylation machinery 
in an in vitro model (Fazakerley, Minard et al. 2018). In our study, at 2 weeks 
of NAC treatment, there were no significant differences in basal insulin and 
glucose levels (Figure 24). This suggest that, although the body is under 
reductive stress as evident from the mitochondrial dysfunction in IWAT 
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(shown in paper I), reduced mitochondrial activity in BAT and reduced lean 
mass gain, there are sufficient compensatory mechanisms available to sustain 
glucose homeostasis and whole-body insulin sensitivity under unchallenged 
conditions. 
4-week high dose NAC treatment induces reductive stress in IWAT and BAT 
To explore the possibility of a dose-dependent reductive stress effect of NAC 
in white and brown adipose tissue, we exposed mice to the three different 
doses during 4 weeks. Indeed, there was a dose- and tissue dependent effects 
of antioxidant treatment on PRDX3 and SOD2, two enzymes whose 
expression is induced by oxidative stress (Whitaker, Patel et al. 2013, Candas 
and Li 2014). IWAT PRDX3 protein expression was increased in the 10 g/L 
NAC group, while IWAT SOD2 protein levels remained similar between 
groups. In BAT, on the other hand, the PRDX3 expression was unaffected, 
but SOD2 was upregulated in a dose-dependent manner, reaching 
significance at 2 and 10 g/L (Figure 25). To understand the different response 
of IWAT and BAT to NAC-induced reductive stress, we analyzed mRNA 
expression levels of several mitochondrial-related genes. In IWAT, along 
with the upregulated expression of PRDX3 protein, there was a simultaneous 
upregulation of peroxisome proliferator-activated receptor gamma 
coactivator 1-beta (Pgc1β), a well-stablished regulator of mitochondrial 
biogenesis and fatty acid β-oxidation (Bouitbir, Charles et al. 2012) 
suggesting that a mitohormesis process has been triggered. In BAT, the 
upregulation of SOD2 protein was connected to a significant reduction of 
Atp6 and cytochrome c oxidase subunit I (CoxI), two mitochondrial 
respiration related-genes, a possible sign of reduced activity in brown 
adipocytes. 
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Figure 25. (top-left) Relative protein expression of PRDX3 in IWAT and (bottom-left) 
relative protein expression of SOD2 in BAT (n=5/group, *p<0.05, **p<0.01, 
****p<0.0001). Relative mRNA expression of adipocyte, mitochondrial and energy 
disposal related genes in (top-right) IWAT and (bottom-right) BAT after 4-week NAC 
treatment (n=5/group, *p<0.05, **p<0.01). 
As an alternative to a mitohormesis-based explanation for the increased 
expression of Pgc1β,  the decrease in BAT mitochondrial activity can lead to 
a compensatory effect in IWAT, similarly to the effect shown in BAT-ablated 
mice (Piao, Zhai et al. 2018). 
Clearly, the response to short-term NAC treatment is cell-specific, and thus 
different between white and brown adipocytes. Different basal levels of 
antioxidant endogenous enzymes due to these adipocytes types’ different 
functions, might explain these protein expression differences after 4 weeks of 
NAC treatment. 
CHRONIC NAC TREATMENT LEADS TO MITOHORMESIS 
16-week high-dose NAC treatment leads to increased mRNA expression of 
browning markers in IWAT 
After 16 weeks of NAC treatment, IWAT and BAT PRDX3 and SOD2 
protein levels were no longer different between groups, implying that an 
adaptation to the reductive stress has occurred  thus normalizing the levels of 
the main components of the previously upregulated mitochondrial 
endogenous antioxidant system. Alternatively, the reductive stress has 
become chronic and no longer triggers an adaptive increase in antioxidant 
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enzymes. The transcriptional response in IWAT of mice treated with the 
highest dose of NAC had a browning-like profile, with significant 
upregulation of Ucp1 (also observed at the protein level in isolated 
mitochondria from IWAT (Figure 31)), Pgc1α, Pgc1β, CoxI and Atp6 
(Figure 26). The increased expression of Pgc1α and β suggest stimulation of 
mitochondrial biogenesis. Surprisingly, Pparγ, a marker of adipocyte 
differentiation and functionality (Chawla, Schwarz et al. 1994), was 
downregulated in IWAT, suggesting that NAC treatment downregulates 
adipocyte renewal or causes adipocyte dedifferentiation. In BAT, no major 
transcriptional differences could be observed, thus the expression of CoxI and 
Atp6 expression had returned to normal levels in the highest NAC dose. 
However, there were some minor differences depending on the dose: CoxIV 
was downregulated in the lowest NAC dose in BAT, and in IWAT from mice 
treated with 2 g/L. One could attribute these differences to a delayed 
hormetic response at the lower doses of NAC or the existence of the minimal 
dose threshold to trigger the hormetic response, i.e. 0.5 and 2 g/L are on the 
left part of the U-shaped typical dose-response of a hormetic process. 
Figure 26. Relative mRNA expression of adipocyte, mitochondrial and energy 
disposal related genes in (top) IWAT and (bottom) BAT after 16-week NAC treatment 
(n=5/group, *p<0.05, **p<0.01). 
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16-week high-dose NAC treatment is associated with reduced fat mass and 
increased mitochondrial function in IWAT 
Only the highest dose of NAC caused a difference in body weight and body 
mass composition. Although food consumption was similar between groups, 
16-week 10 g/L NAC treatment led to a 22 % reduction in body weight and a 
5.8 % reduction in body length compared to control (Figure 27). 
Figure 27. (left) Body weight, (center) fat percentage, (right) lean mass 
(normalized to body length) of C57BL/6J mice treated for 16 weeks with either 
water or NAC 0.5, 2 or 10 g/L solution (n=5/group, *p<0.05, **p<0.01). 
The reduced body weight gain was mainly due to a reduction in fat mass, 
responsible for 88 % of the lower body mass. A reduction in lean mass gain 
was thus responsible for the remaining 12 %. Moreover, the white adipose 
tissue weight was severely affected by 10 g/L NAC treatment with a 38 % 
reduction in GWAT weight and a 53 % reduction in IWAT weight (Figure 
28). 
Figure 28. (left) IWAT, (center) GWAT and (right) BAT weight of C57BL/6J mice 
treated for 16 weeks with either water or NAC 0.5, 2 or 10 g/L solution (n=5/group, 
**p<0.01, ***p<0.001). 
As judged by the mRNA expression, the primary target for a possible 
mitohormetic response of antioxidant treatment is white adipose tissue where 
chronic high-dose NAC treatment was associated with an upregulation of 
browning and mitochondrial genes. To further study the mitochondrial 
function in white adipose tissue at this stage, we performed OCR analysis of 
freshly dissected IWAT after 16 week-NAC treatment. IWAT samples from 
mice treated with the lowest dose of NAC showed a significant reduction in 
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OCR, while the OCR of IWAT samples from mice treated with higher doses 
was similar to the untreated control (Figure 29). This reduction in OCR in 
response to chronic low-dose NAC treatment can be interpreted as a sign of 
reductive stress, but the mitochondrial antioxidant enzymes PRDX3 and 
SOD2 were not different from controls. Altogether, we interpret these data as 
a sign of chronic reductive stress in IWAT from mice treated with the lowest 
NAC dose i.e the NAC dose is not high enough to trigger sufficient 
adaptation to the pro-oxidant effects of NAC leading to a sustained reduction 
of OCR limiting the mitochondrial ROS production. 
Figure 29. IWAT OCR measured in fresh tissue samples from C57BL/6J mice treated 
for 16 weeks with either water or NAC 0.5, 2 or 10 g/L solution (n=3/group, 
*p<0.05). 
Based on the transcriptional response, we had anticipated increased IWAT 
OCR in mice treated with the highest NAC dose. OCR measurements of 
whole adipose tissue have however its limitations as discussed previously in 
the Methods section. We thus decided to perform a more thorough 
examination of the mitochondrial function in IWAT and BAT through 
analysis of isolated mitochondria. In support of a mitohormetic response in 
IWAT in mice on chronic high-dose NAC treatment, we found increased 
basal and ATP production-linked respiration in isolated IWAT mitochondria. 
The uncoupled respiration and the respiratory control ratio (RCR) showed 
however no difference likely due to large variation within groups. In contrast, 
isolated BAT mitochondria showed no difference in OCR in any parameter 
(Figure 30 and data not shown). 
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Figure 30. (top-left) Basal respiration, (top-right) ATP production, (bottom-left) 
uncoupled respiration and (bottom-right) RCR measured in isolate mitochondria 
from IWAT samples from C57BL/6J mice treated for 16 weeks with either water or 
NAC 10 g/L solution (n=3/group, *p<0.05, **p<0.01). 
To delineate whether these changes in the mitochondrial performance can be 
attributed to changes in protein components of the electron transport chain, 
we analyzed OXPHOS proteins in isolated IWAT mitochondria (Figure 31). 
This analysis showed major differences between control mice and mice 
treated with the highest NAC dose; IWAT complex I and II protein members 
(NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8 
(NDUF8B) and Succinate dehydrogenase [ubiquinone] iron-sulfur subunit 
(SDHB) respectively) were markedly upregulated in the NAC-treated group. 
Complex I and II are receiving electrons from respectively, NADH and 
FADH2 that should increase during reductive stress. Thus, it is possible that 
changed activity of these complexes is driving the observed mitochondrial 
changes in IWAT. There was also a trend towards an upregulation of 
complex IV. Complex V was however ubiquitously expressed and was 
therefore used as a loading control for the relative quantification of UCP1. 
Even though we did not detect increased uncoupled respiration, the 
mitochondria from NAC-treated animals displayed a 5-fold increase in UCP1 
protein expression. We attribute this discrepancy to the rather large 
variability in the OCR analysis. It is possible that the mitochondria function 
becomes more or less altered by the isolation procedure. 
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Figure 31. (top-right) UCP1 and (top-left) OXPHOS complexes protein expression: 
representative blot and (middle and bottom) quantification from isolate mitochondria 
from IWAT samples from C57BL/6J mice treated for 16 weeks with either water or 
NAC 10 g/L solution (n=3/group, *p<0.05, **p<0.01). 
Similar to our study, 8-week treatment with daily NAC IP injections has been 
shown to reduce body weight in a dose-dependent manner (Kim, Ryu et al. 
2006). This effect was in part explained by a reduction of GWAT weight, 
while IWAT weight remained unaffected (Kim, Ryu et al. 2006) possibly due 
to a different administration method and/or shorter treatment time compared 
to our study. The reduced GWAT weight gain detected by Kim and 
colleagues was attributed to NAC’s inhibitory effect on adipocyte 
differentiation (Kim, Ryu et al. 2006). The downregulation of Pparγ mRNA 
expression we observed in IWAT adds support for such hypothesis, but we 
propose that the IWAT browning phenotype also plays a role for the reduced 
fat mass through increased energy expenditure. On the other hand, we saw no 
signs of enhanced mitochondrial functionality in BAT, the primary site for 
non-shivering thermogenesis. Moreover, whole-body energy balance is 
regulated by the brain implying that it is likely to also be a central component 
involved in the lowered body weight in NAC-treated mice.  
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16-week high-dose NAC treatment is associated with improved whole-body 
insulin sensitivity 
To assess if the changes in body composition and IWAT mitochondrial 
function alter whole-body metabolism, we measured fasting glucose and 
insulin levels in mice treated for 16 weeks with of NAC. While basal glucose 
levels were similar between groups (data not shown), the insulin levels were 
affected in a NAC dose dependent manner. Mice receiving the highest NAC 
dose displayed a significant improvement in insulin sensitivity as judged by 
reduced fasting insulin levels and HOMA-IR index (Figure 32). 
Figure 32. (left) Fasting serum insulin levels and (right) calculated HOMA-IR 
indexes in C57BL/6J mice given water or NAC 0.5, 2 or 10 g/L solution (n=5/group, 
*p<0.05). 
Such NAC-induced improvement in insulin sensitivity has been reported 
previously in hyperinsulinemic patients (1.8 g/day for 6 weeks) (Fulghesu, 
Ciampelli et al. 2002), in an insulin resistant rat model (1-2 g/L, 
corresponding to 2 g/kg/day in drinking water) (El Midaoui, Ismael et al. 
2008) and in high-fat diet fed mice (2 g/L in drinking water for 11 weeks) 
(Ma, Gao et al. 2016). In all these studies, there was a reversal of insulin 
resistance, attributed to NAC’s antioxidant properties and the consequent 
anti-inflammatory effect. However, in our study mice are normoinsulinemic 
at the starting point with a completely unchallenged metabolic homeostasis, 
yet they are experiencing insulin sensitization together with a browning-like 
process in white adipose tissue when treated with 10 g/L of NAC for 16 
weeks. Moreover, mice treated with the lowest dose displayed significantly 
increased insulin levels without a change in their glucose levels, i.e. a sign of 
insulin resistance (although not severe enough to change the HOMA-IR). 
This increase in insulin levels could be attributed to the lack of a 
mitohormetic response and thus the chronification of reductive stress as 
evident from the reduced IWAT respiration. 
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CONCLUDING REMARKS ON PAPER II 
NAC treatment of unchallenged chow-fed mice results in a biphasic behavior 
of adipose tissue where the final outcome on mitochondrial function is tightly 
connected to both the adipose tissue type and the dosage. Short-term (2 
weeks) high dose NAC treatment (10 g/L) increases the levels of the 
mitochondrial antioxidant enzymes in IWAT and BAT, and reduces 
mitochondrial respiration in BAT. After 16 weeks of high dose NAC 
treatment, BAT shows neither signs of compromised nor improved 
mitochondrial function indicating that BAT adapts, but does not 
supercompensate, to the reductive stress. IWAT, on the other hand, shows 
improved mitochondrial function in response to 16-week high dose NAC 
treatment as judged by both gene expression and mitochondrial analyses. 
Interestingly, mice kept on the lowest NAC dose (0.5 g/L), develop slight 
insulin resistance and display reduced IWAT OCR. We believe this negative 
outcome from low dose NAC treatment is due to chronic reductive stress and 
thus insufficient upregulation of e.g. mitochondrial antioxidant enzymes, 
OXPHOS proteins and mitochondrial biogenesis. 
In conclusion, this study demonstrates that chronic NAC treatment, provided 
that the dose is adequate, can lead to a mitohormetic process in white adipose 
tissue associated with reduced fat mass and increased insulin sensitivity. 
Importantly, these results challenge the current paradigm where antioxidants 
primarily are thought to act as scavengers and thereby improve health by a 
simple reduction of oxidative stress. Moreover, our work may also explain 
the lack of effects or even the deleterious effects of NAC in some settings. 
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5 CONCLUSIONS AND FUTURE 
PERSPECTIVES 
In this thesis we have studied the effects of antioxidant treatment on 
mitochondrial function in white and brown adipose tissue in vitro and in vivo. 
Our main conclusions from these studies are: 
1. β3-AR activation in 3T3-L1 adipocytes leads to increased 
ROS production and increased UCP1 expression. These 
effects cannot be prevented by 24 h antioxidant 
pretreatment. 
2. 24 h NAC pretreatment of 3T3-L1 adipocytes drives 
mitochondrial changes resulting in reduced basal oxygen 
consumption associated with elevated glycolysis. Thus, 
antioxidants cannot be used as tools to study the role of 
ROS in β3-AR-mediated responses of adipocytes. 
3. 2-week NAC treatment (1 g/L in drinking water) of 
unchallenged chow-fed mice leads to reductive stress in 
adipose tissue, associated with reduced β3-AR agonist-
mediated browning of IWAT and mitochondrial 
dysfunction in BAT. 
4. NAC treatment of unchallenged chow-fed mice leads to a 
biphasic response where the effect on mitochondrial 
function in adipose tissue is tightly connected to the 
adipose tissue type and the treatment dose and duration. 
5. Chronic NAC treatment can lead to a mitohormetic process 
in IWAT i.e. supercompensation to reductive stress leading 
to increased mitochondrial function (browning) associated 
with reduced fat mass and increased insulin sensitivity. 
Antioxidant therapy is broadly used to treat conditions where oxidative stress 
is thought to play a central role. Antioxidants are also used in basic research 
due to their potential to scavenge ROS. The obtained results from clinical and 
experimental antioxidant studies are contradictory. We believe our data, 
which are summarized above, provide both a plausible explanation for many 
of these contradictory and/or controversial results and a new insight on how 
to better design antioxidant treatment studies. Nevertheless, further 
investigations are required to e.g. clarify the detailed mechanism that drives 
insulin sensitization or resistance depending on the dose, thus to understand 
the metabolic effects of antioxidants and the different effects that 
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antioxidants have on different adipose tissue types. Moreover, a more 
extensive study that includes also other types of antioxidants e.g. 
mitochondria-targeting antioxidants such as MitoQ, and other tissues (e.g. 
liver, pancreas or muscle) is highly recommended to evaluate possible pro-
oxidative or hormetic effects. Overall, a better understanding of the 
consequences of chronic NAC treatment or a combination of antioxidants 
could pave the way for new treatments and applications. 
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